Search
forLearn
3 / 3 resultslearn Estradiol
an estrogen promoting hair regrowth more commonly used in women
learn Vitamin D
vitamin you should probably be taking for general health might also help your hair a little
Research
5 / 1000+ results![Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia](/images/research/83104a71-0192-4d7a-a555-e1ed39d8352c/small/3631.jpg)
research Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.
research Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
![Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk](/images/research/c392fda4-86a4-4c93-9624-8f31ef7a0e00/small/27896.jpg)
research Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.
![Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population](/images/research/af041778-90a5-46a0-855f-1990b65490d7/small/20767.jpg)
research Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.
![Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population](/images/research/7d52e2e4-391a-44ac-856b-d7c4968e91da/small/14643.jpg)
research Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.
Community Join
5 / 121 resultscommunity 6 Month Progress (Sept 2021-Mar 2022) Fin,Min,Microneedling,Biotin, Ketoconazole Shampoo
User shared 6-month progress using Fin, Min, Microneedling, Biotin, and Ketoconazole Shampoo for hair loss. They microneedle once a week, use 1.25 mg Fin daily, and apply topical Min twice a day.
community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.
community A story about why it matters to fight this
A user shared their experience with hair loss treatments, including finasteride, minoxidil, and RU58841, which improved their hair from a diffuse NW3 to a solid NW2 - 2.5. They noticed significant changes in how people treated them after regrowing their hair, suggesting that attractiveness can greatly impact social interactions and opportunities.
community switched from topical to oral minoxidil (topical mixed with water) 3 months ago and aside from being much easier i’ve also had much more density overall. My results aren’t even finished yet!
This user discussed using oral minoxidil as a hair loss treatment, and was cautioned against mixing topical minoxidil with water and drinking it due to potential side effects and risks. Other users shared their concerns about the dangers of self-prescribing medications without consulting a doctor.
community Anyone wanna try and interview the developers of RU?
The conversation discusses arranging an interview with the developers of RU58841 to clarify its safety and reasons for halted research, with some users expressing concerns about potential risks and others citing financial reasons for the discontinuation of studies. Specific treatments mentioned include RU58841, minoxidil, and finasteride.